Compare Mutual Funds

Pros
Beats FD returns for both 3Y & 5Y duration.

Beats FD returns for both 3Y & 5Y duration.

Larger AUM within category.

Larger AUM within category.

Beats FD returns for both 3Y & 5Y duration.

Beats FD returns for both 3Y & 5Y duration.

Cons
3Y returns in the bottom 25% of the category.

3Y returns in the bottom 25% of the category.

-

INDMoney rank
4/8
6/8
Category

Equity, Sector - Healthcare

Equity, Sector - Healthcare

Fund Age

10 Years 4 Months

13 Years 5 Months

Fund AUM

₹1301 Cr

₹8306 Cr

Min Investment
  1. SIP ₹100
  2. Lumpsum ₹5000
  1. SIP ₹100
  2. Lumpsum ₹5000
Expense Ratio

0.69%

0.91%

Exit Load

0.25%

1%

Benchmark Index

Nifty Pharma TR INR

BSE Healthcare TR INR

No of Holdings

36

39

Top 5 Holdings
  1. Sun Pharmaceuticals Industries Ltd(9.66%)
  2. Max Healthcare Institute Ltd Ordinary Shares(6.78%)
  3. Divi's Laboratories Ltd(5.94%)
  4. Abbott India Ltd(5.6%)
  5. HealthCare Global Enterprises Ltd(5.04%)
  1. Sun Pharmaceuticals Industries Ltd(13.08%)
  2. Lupin Ltd(7.99%)
  3. Divi's Laboratories Ltd(6.56%)
  4. Dr Reddy's Laboratories Ltd(5.81%)
  5. Cipla Ltd(5.67%)
No of Sectors

2

1

Top 3 Sectors
  1. Health(96.58%)
  2. Basic Materials(3.42%)

Health

(100%)

Equity %

97.59%

99.7%

Debt %

-

-

P/E

41.15

35.73

P/B

6.83

5.7

Credit Quality

-

-

Modified Duration

-

-

YTM

-

-

1-Month Return

-4.43%

-2.91%

3-Month Return

-4.84%

-1.77%

6-Month Return

-5.14%

-1.1%

1-Year Return

1.06%

3.24%

3-Year Return

24.51%

24.53%

5-Year Return

16.83%

16.64%

Sharpe

1.13

1.17

Alpha

1

0.22

Beta

0.95

0.9

Standard Deviation

16.16

15.21

Information Ratio

0.04

-0.47

Description

Tata India Pharma & Healthcare Fund is an equity fund.The fund could potentially beat inflation in the long-run.

Nippon India Pharma Fund is an equity fund.The fund could potentially beat inflation in the long-run.

Managers

Rajat Srivastava

Sailesh Raj Bhan, Kinjal Desai, Lokesh Maru, Divya Sharma

Most Popular Comparisons